NEUROPACE, INC. (NPCE) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 59.01M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 96.99M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | $59.01M | (m) | (m) | $96.99M | (m) |
| 2026-03-31 | (m) | (m) | (m) | $59.02M | (m) | (m) | $98.90M | (m) |
| 2025-12-31 | (m) | (m) | (m) | $58.88M | (m) | (m) | $105.56M | (m) |
| 2025-09-30 | (m) | (m) | (m) | $58.75M | (m) | (m) | $107.25M | (m) |
| 2025-06-30 | (m) | (m) | (m) | $58.62M | (m) | (m) | $106.11M | (m) |
| 2025-03-31 | (m) | (m) | (m) | $59.79M | (m) | (m) | $110.20M | (m) |
| 2024-12-31 | (m) | (m) | (m) | $59.52M | (m) | (m) | $94.65M | (m) |
| 2024-09-30 | (m) | (m) | (m) | $59.27M | (m) | (m) | $96.30M | (m) |
| 2024-06-30 | (m) | (m) | (m) | $59.02M | (m) | (m) | $94.39M | (m) |
| 2024-03-31 | (m) | (m) | (m) | $58.04M | (m) | (m) | $98.85M | (m) |
| 2023-12-31 | (m) | (m) | (m) | $56.95M | (m) | (m) | $107.65M | (m) |
| 2023-09-30 | (m) | (m) | (m) | $55.89M | (m) | (m) | $99.30M | (m) |
| 2023-06-30 | (m) | (m) | (m) | $54.85M | (m) | (m) | $102.23M | (m) |
| 2023-03-31 | (m) | (m) | (m) | $53.86M | (m) | (m) | $106.27M | (m) |
| 2022-12-31 | (m) | (m) | (m) | $52.91M | (m) | (m) | $114.11M | (m) |
| 2022-09-30 | (m) | (m) | (m) | $51.95M | (m) | $85.41M | $120.47M | (m) |
| 2022-06-30 | (m) | (m) | (m) | $51.02M | (m) | $92.41M | $118.54M | (m) |
| 2022-03-31 | (m) | (m) | (m) | $50.12M | (m) | $103.17M | $128.98M | (m) |
| 2021-12-31 | (m) | (m) | $0.00 | $49.85M | (m) | (m) | $133.56M | (m) |
| 2021-09-30 | (m) | (m) | $0.00 | $49.58M | (m) | $123.33M | $141.26M | (m) |
| 2021-06-30 | (m) | (m) | $0.00 | $49.35M | (m) | $127.92M | $146.97M | (m) |
| 2021-03-31 | (m) | (m) | $3.59M | $49.56M | (m) | $30.53M | $50.32M | (m) |
| 2020-12-31 | (m) | (m) | $2.04M | $50.82M | (m) | $38.08M | $55.95M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |